NCT06696534 Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
| NCT ID | NCT06696534 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ADVANCED MARKER DISCOVERY S.L. |
| Condition | Screening for Colon Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-05-19 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2025-05-19 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are: * Values of experience of participants into screening programme. * Values of preferences of participants for screening methods. Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.
Eligibility Criteria
Inclusion Criteria: * Participants ages from 50 to 69 years (both included) at the time of informed consent signed. * Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center. * Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form. Exclusion Criteria: * Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form. * Participants with a previous colonoscopy in consequence of a FOBT positive result. * Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.
Contact & Investigator
Maria A Perez, MD
PRINCIPAL INVESTIGATOR
Primary Health Care Centre Mar Báltico
Frequently Asked Questions
Who can join the NCT06696534 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 69 Years, studying Screening for Colon Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06696534 currently recruiting?
Yes, NCT06696534 is actively recruiting participants. Contact the research team at mjimenez@amadix.com for enrollment information.
Where is the NCT06696534 trial being conducted?
This trial is being conducted at Lisbon, Portugal, Madrid, Spain.
Who is sponsoring the NCT06696534 clinical trial?
NCT06696534 is sponsored by ADVANCED MARKER DISCOVERY S.L.. The principal investigator is Maria A Perez, MD at Primary Health Care Centre Mar Báltico. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.